IMPORTANT SAFETY INFORMATION:
Exall™-D Liquid (carbetapentane citrate, pseudoephedrine hydrochloride and guaifenesin 10 mg/30 mg/100 mg per 5 mL) is indicated for the temporary relief of productive and non-productive cough accompanying respiratory tract congestion associated with the common cold, influenza, sinusitis, and bronchitis; for the relief of eustachian tube congestion; and for adjunctive therapy in serous otitis media. Exall™-D Liquid is contraindicated in infants and newborns, and in patients with a known hypersensitivity to any of the ingredients and in patients receiving monoamine oxidase inhibitor (MAOI) therapy, including 14 days after stopping. Before prescribing any medication to suppress or modify cough, it is important that the underlying cause of the cough is identified.

Patients should be instructed to take Exall™-D Liquid only as prescribed. Do not exceed the recommended dose. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a physician.

For full prescribing information, please click here.

If you do not have Adobe® Acrobat® Reader for viewing the pdfs shown above, you may download it free of charge by clicking here.